← Eichor
Study identifier: NCT04166656 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

Condition: Splenectomy  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhasePhase 3
Planned participants84
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of the study is to evaluate the immunological response and tolerance of 3 vaccine strategies against meningococcus B, a potentially fatal invasive infection.

This description comes directly from the study's public registry record.

Talk to the study team

Odile LAUNAY, MD,PhD  ·  +33(01)58 41 28 58  ·  odile.launay@aphp.fr

Audrey BECLIN-CLABAUX  ·  +33 (0)1 58 41 33 82  ·  audrey.clabaux@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

I-REIVAC/CIC1417 Cochin Hospital, AP-HPParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04166656